ASBV
Asia, Guangdong, China, Shenzhen'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
ASBV focuses on early and mid-term venture capital investments.
Investor Profile
ASBV has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Biotechnology, Health Care, Product Research.
Stage Focus
- Series A (50%)
- Seed (50%)
Country Focus
- China (50%)
- United States (50%)
Industry Focus
- Biotechnology
- Health Care
- Product Research
- Artificial Intelligence (Ai)
- Genetics
- Medical
- Pharmaceutical
- Precision Medicine
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
